Palatin Technologies, Inc. (PTN)

NYSE American - Nasdaq Real Time Price. Currency in USD

Add to watchlist

0.3070

+0.0280

(+10.04%)

At close: 04:00PM EDT

0.2900

-0.02

(-5.54%)

After hours:

07:36PM EDT

Advertisement

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

Zacks
Palatin Technologies, Inc. (PTN) Reports Q3 Loss, Misses Revenue Estimates
Palatin Technologies, Inc. (PTN) delivered earnings and revenue surprises of 0% and 62.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
PR Newswire
Palatin Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, today announced results for its fiscal third quarter ended March 31, 2022.
Zacks
PhaseBio Pharmaceuticals (PHAS) Reports Q1 Loss, Misses Revenue Estimates
PhaseBio Pharmaceuticals (PHAS) delivered earnings and revenue surprises of 65.67% and 98%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Advertisement